These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 21370997)

  • 1. Transfusion rate and prevalence of unexpected red blood cell alloantibodies in women undergoing hysterectomy for benign disease.
    Thoestesen LM; Rasmussen KL; Lauszus FF; Hansen CT; Titlestad KE; Larsen R
    Acta Obstet Gynecol Scand; 2011 Jun; 90(6):636-41. PubMed ID: 21370997
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Red blood cell alloantibody frequency, specificity, and properties in a population of male military veterans.
    Tormey CA; Fisk J; Stack G
    Transfusion; 2008 Oct; 48(10):2069-76. PubMed ID: 18631165
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence and specificities of red blood cell alloantibodies in transfused Ugandans with different diseases.
    Natukunda B; Schonewille H; van de Watering L; Brand A
    Vox Sang; 2010 Feb; 98(2):167-71. PubMed ID: 19708889
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cesarean section: is pretransfusion testing for red cell alloantibodies necessary?
    Larsen R; Titlestad K; Lillevang ST; Thomsen SG; Kidholm K; Georgsen J
    Acta Obstet Gynecol Scand; 2005 May; 84(5):448-55. PubMed ID: 15842209
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Red blood cell alloimmunization in sickle cell disease patients in Uganda.
    Natukunda B; Schonewille H; Ndugwa C; Brand A
    Transfusion; 2010 Jan; 50(1):20-5. PubMed ID: 19821949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coexistence of autoantibodies and alloantibodies to red blood cells due to blood transfusion.
    Ahrens N; Pruss A; Kähne A; Kiesewetter H; Salama A
    Transfusion; 2007 May; 47(5):813-6. PubMed ID: 17465945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alloimmunizations following blood transfusions.
    Hundrić-Haspl Z; Juraković-Loncar N; Grgicević D; Balija M
    Acta Med Croatica; 1994; 48(4-5):193-7. PubMed ID: 7534524
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of HLA antibodies in transfused patients with and without red cell antibodies.
    Buetens O; Shirey RS; Goble-Lee M; Houp J; Zachary A; King KE; Ness PM
    Transfusion; 2006 May; 46(5):754-6. PubMed ID: 16686842
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk of alloimmunization and delayed hemolytic transfusion reactions in patients with sickle cell disease.
    Cox JV; Steane E; Cunningham G; Frenkel EP
    Arch Intern Med; 1988 Nov; 148(11):2485-9. PubMed ID: 3142382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification and evaluation of false-negative antibody screens.
    Powers A; Chandrashekar S; Mohammed M; Uhl L
    Transfusion; 2010 Mar; 50(3):617-21. PubMed ID: 19951323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of new maternal alloantibodies after intrauterine transfusion for severe Rhesus disease.
    Watson WJ; Wax JR; Miller RC; Brost BC
    Am J Perinatol; 2006 Apr; 23(3):189-92. PubMed ID: 16586229
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Immunohematologic study in 112 patients with myelodysplastic syndromes: 10-year analysis].
    Arriaga F; Bonanad S; Larrea L; de la Rubia J; López F; Sanz MA; Sanz G; Marty ML
    Sangre (Barc); 1995 Jun; 40(3):177-80. PubMed ID: 7570268
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Delayed and acute hemolytic transfusion reactions resulting from red cell antibodies and red cell-reactive HLA antibodies.
    Takeuchi C; Ohto H; Miura S; Yasuda H; Ono S; Ogata T
    Transfusion; 2005 Dec; 45(12):1925-9. PubMed ID: 16371045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinically significant red cell alloantibodies in patients with warm autoimmune hemolytic anemia.
    Haspl ZH; Tomicić M; Grgicević D
    Acta Med Croatica; 2001; 55(4-5):149-52. PubMed ID: 12398016
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety in transfusion practices. Red cell compatibility testing issues.
    Shulman IA
    Clin Lab Med; 1992 Dec; 12(4):685-700. PubMed ID: 1286558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Red cell alloantibodies in Lao blood donors.
    Keokhamphoui C; Urwijitaroon Y; Kongphaly D; Thammavong T
    Southeast Asian J Trop Med Public Health; 2014 Jan; 45(1):194-7. PubMed ID: 24964670
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Red cell immunization in beta thalassaemia major.
    Bhatti FA; Salamat N; Nadeem A; Shabbir N
    J Coll Physicians Surg Pak; 2004 Nov; 14(11):657-60. PubMed ID: 15530273
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incomplete pretransfusion testing leads to surgical delays.
    McWilliams B; Yazer MH; Cramer J; Triulzi DJ; Waters JH
    Transfusion; 2012 Oct; 52(10):2139-44; quiz 2145. PubMed ID: 22348700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Delayed hemolytic transfusion reaction due to anti-S antibody in patient with anti-Jk(a) autoantibody and multiple alloantibodies.
    Guastafierro S; Sessa F; Cuomo C; Tirelli A
    Ann Hematol; 2004 May; 83(5):307-8. PubMed ID: 15064858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regional registry of patient alloantibodies: first-year experience.
    Schwickerath V; Kowalski M; Menitove JE
    Transfusion; 2010 Jul; 50(7):1465-70. PubMed ID: 20345565
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.